Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Tolerogenic insulin peptide therapy precipitates type 1 diabetes.

Bergman ML, Lopes-Carvalho T, Martins AC, Grieco FA, Eizirik DL, Demengeot J.

J Exp Med. 2017 Jul 3;214(7):2153-2156. doi: 10.1084/jem.20160471. Epub 2017 May 23.

2.

Old dogs and new tricks: defective peripheral regulatory T cell generation in aged mice.

Lopes-Carvalho T, Coutinho A.

Eur J Immunol. 2013 Oct;43(10):2534-7. doi: 10.1002/eji.201344029.

3.

Marginal zone B cells in lymphocyte activation and regulation.

Lopes-Carvalho T, Foote J, Kearney JF.

Curr Opin Immunol. 2005 Jun;17(3):244-50. Review.

PMID:
15886113
4.

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J.

Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4091-6. Epub 2005 Mar 7.

5.

Marginal zone B cell physiology and disease.

Lopes-Carvalho T, Kearney JF.

Curr Dir Autoimmun. 2005;8:91-123. Review.

PMID:
15564718
6.

Development and selection of marginal zone B cells.

Lopes-Carvalho T, Kearney JF.

Immunol Rev. 2004 Feb;197:192-205. Review.

PMID:
14962196
7.

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide.

Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J.

J Exp Med. 2003 Feb 17;197(4):403-11.

Supplemental Content

Loading ...
Support Center